Type of security: Stock
Sector: Health Care
Industry: Other Pharmaceuticals
Market Capitalization: 27.03 B
The data is delayed by 15 minutes.
Description: Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, specialty pharmaceutical, and consumer products to retailers, including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers; hospitals; and other healthcare providers. This segment offers distribution, inventory management, data reporting, new product launch support, and contract pricing and chargeback administration services to pharmaceutical manufacturers; operates nuclear pharmacies and cyclotron facilities that manufacture, prepare, and deliver radiopharmaceuticals for use in nuclear imaging and other procedures in hospitals and physician offices; franchises retail pharmacies under the Medicine Shoppe and Medicap brands; provides pharmacy ser
|Shares Outstanding||325.82 M||EPS||4.47||EPS Growth - 4 Quarters||92.37%||EPS Growth - Q/Q||44%|
|EPS Growth - Y/Y||-4052.63%||Sales Growth - 4 Quarters||10.84%||Sales Growth - Q/Q||-0.63%||P/E||16.78|
|P/E To EPS Growth||0.42||P/S||0.28||P/BV||4.24||Price/Cash Per Share|
|Price/Free Cash Flow||11.88||ROA||4.14%||ROE||18.12%||ROI|
|Current Ratio||1.2||Quick Ratio||0.64||Long Term Debt/Equity||1.15||Debt Ratio||2.57|
|Gross Margin||5.63%||Operating Margin||2.03%||Net Profit Margin||1.18%||Dividend Payout Ratio||-38.91%|
|Cash From Financing Activities||-968 M||Cash From Investing Activities||-386 M||Cash From Operating Activities||1.67 B||Gross Profit||1.46 B|
|Net Profit||365 M||Operating Profit||591 M||Total Assets||27.89 B||Total Current Assets||19.63 B|
|Total Current Liabilities||16.4 B||Total Debt||4 B||Total Liabilities||21.52 B||Total Revenue||25.38 B|
|High 52 week||55.67||Low 52 week||41.32||Last close||47.9||Last change||2.39%|
|RSI||55.1||Average true range||1.05||Beta||0.74||Volume||879.63 K|
|Simple moving average 20 days||2.75%||Simple moving average 50 days||6.25%||Simple moving average 200 days||2.19%|
|Performance Week||6.54%||Performance Month||-1.06%||Performance Quart||7.36%||Performance Half||3.51%|
|Performance Year||-10.76%||Performance Year-to-date||-8.52%||Volatility daily||1.27%||Volatility weekly||2.85%|
|Volatility monthly||5.84%||Volatility yearly||20.22%||Relative Volume||232.25%||Average Volume||2.79 M|
|New High||New Low|
2019-11-21 08:08:01 | Here's Why You Should Hold on to Masimo MASI Stock Now
2019-11-20 09:08:02 | Here's Why You Should Retain PRA Health PRAH Stock Now
2019-11-19 10:02:03 | 5 Excellent GARP Stocks With Discounted PEG
2019-11-19 09:50:02 | Cooper Companies' CVI Unit Gets FDA Nod, To Boost Eye Health
2019-11-19 09:25:02 | Here's Why You Should Hold on to Becton, Dickinson Stock Now
2019-11-19 08:51:01 | Why Cardinal Health CAH Could Be a Top Value Stock Pick
2019-11-18 08:19:01 | Here's Why You Should Hold on to PerkinElmer Stock for Now
2019-11-14 10:15:03 | Here's Why You Should Hold Cooper Companies COO Stock Now
2019-11-14 07:19:46 | Edited Transcript of CAH earnings conference call or presentation 7-Nov-19 1:00pm GMT
2019-11-13 06:37:11 | Is Deep Value ETF DVP a Strong ETF Right Now?
2019-11-08 07:09:08 | Cardinal Health agrees to pay $5.63B to settle claims in opioid crisis
2019-11-08 05:55:23 | Is Cardinal Health, Inc. NYSE:CAH Trading At A 23% Discount?
2019-11-07 17:04:21 | Cardinal Health Inc wins $2.25 billion U.S. defense contract -Pentagon
2019-11-07 14:33:30 | Teva climbs despite earnings miss
2019-11-07 14:05:00 | Teva’s CEO Says Opioid Deal Could Be Done By End of the Year
2019-11-07 10:40:00 | Teva and Other Opioid Defendant Stocks Jump on Strong Earnings
2019-11-07 09:41:02 | Cardinal Health CAH Q1 Earnings & Revenues Beat Estimates
2019-11-07 08:05:01 | Cardinal Health CAH Q1 Earnings and Revenues Top Estimates
2019-11-07 07:30:00 | Cardinal Health reports $4.9 billion loss due to opioid agreements
2019-11-07 06:50:00 | Cardinal Health Reports First Quarter Results for Fiscal Year 2020
2019-11-06 09:42:02 | Medical Products' Nov 7 Earnings Roster: ABC, CAH & More
2019-11-06 08:57:01 | Why Earnings Season Could Be Great for Cardinal Health CAH
2019-11-04 10:46:03 | Can Pharmacy Services Drive CVS Health's CVS Q3 Earnings?
2019-11-04 08:55:01 | What's in the Cards for Cardinal Health CAH in Q1 Earnings?
2019-11-04 08:07:01 | What's in the Cards for DaVita DVA This Earnings Season?
2019-11-01 12:32:40 | Can All-Line Growth Boost CVS Health's CVS Q3 Earnings?
2019-10-31 10:34:02 | Cardinal Health CAH Expected to Beat Earnings Estimates: Should You Buy?
2019-10-31 07:34:11 | Will Genetic Testing Drive Invitae's NVTA Q3 Earnings?
2019-10-30 08:29:12 | Can Dental Growth Drive Henry Schein's HSIC Q3 Earnings?
2019-10-30 08:22:12 | Can BD Medical Drive Becton, Dickinson's BDX Q4 Earnings?
2019-10-29 09:12:01 | What's in Store for Tandem Diabetes' TNDM Q3 Earnings?
2019-10-26 07:00:00 | SHAREHOLDER ALERT: The Law Offices of Timothy L. Miles Reminds Investors Cardinal Health, Inc. CAH Sued for Misleading Shareholders; Cardinal Health Shareholders Urged to Contact the Firm
2019-10-25 17:49:10 | 5 Eerily Low Price-Sales Stocks With High Financial Strength
2019-10-25 10:50:02 | PerkinElmer PKI to Report Q3 Earnings: What's in Store?
2019-10-25 10:25:02 | ABIOMED ABMD to Report Q2 Earnings: What's in the Offing?
2019-10-24 11:18:00 | Johnson & Johnson Cut Its Earnings in a Late-Night Filing. Here’s Why.
2019-10-24 10:49:02 | What's in the Offing for Stryker's SYK Earnings in Q3?
2019-10-24 08:27:12 | McKesson MCK to Report Q2 Earnings: What's in the Offing?
2019-10-23 09:52:01 | Can Global Industrial Unit Drive Ecolab's ECL Q3 Earnings?
2019-10-22 12:21:16 | Cardinal Health to transfer 200 finance employees to new Genpact office in Dublin
2019-10-22 08:44:12 | Is Deep Value ETF DVP a Strong ETF Right Now?
2019-10-21 17:50:01 | Drug Companies Strike $48 Billion Deal In Opioid Crisis With Four States
2019-10-21 16:13:21 | Drug Firms Ink Last-Minute $260 Million Deal Ahead Of Opioid Trial
2019-10-21 15:28:00 | Teva Stock Jumps After the Company Reached a Tentative Opioid Deal
2019-10-21 14:08:00 | Major drug companies agree to pay $260 million settlement in opioid case
2019-10-21 13:54:43 | Four major players in the US opioid crisis reached a tentative deal in Ohio
2019-10-21 13:03:06 | Get Real. There Will Be a Global Opioid Settlement.